Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-24

Clinical Trial Update: Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy [NA]

View source ↗

Summary

Clinical trial evaluating whether probucol combined with valsartan reduces proteinuria in diabetic nephropathy; sponsor Guangdong Provincial People's Hospital; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probucol (Probucol)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Type 2 Diabetes Mellitus, Nephropathy | NA | Status: UNKNOWN